Pharmafile Logo
Pharmafocus logo
Advanced Search
Blog footer

Digital Pharma: Facebook first from Janssen

October 8, 2010
Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, ipad, iphone, youtube

Janssen UK has officially launched its new psoriasis disease awareness campaign, part of which includes the first pharma Facebook page …

News

NHS reforms moving ‘too fast’

October 8, 2010
NHS, government, king's fund

The government’s plans to reform the NHS are moving too far according to health think tank the King’s Fund. Radical …

News

Novo Nordisk invests $73m to boost diabetes drug production

October 8, 2010
Manufacturing and Production Novo Nordisk, diabetes, insulin

Novo Nordisk has announced another major expansion of its manufacturing capacity for diabetes products, setting aside $73 million to expand …

News

AZ plans heart attack study for Brilique

October 8, 2010
Research and Development, Sales and Marketing AstraZeneca, Brilinta, Brilique

AstraZeneca is due to begin enrolling patients into a new study of its oral antiplatelet Brilique (ticagrelor) before the end …

News

Going Digital: Challenge your assumptions

October 8, 2010
Medical Communications PraeMedica, digital, digital marketing, digital pharma

A wise man once said: “The secret to surviving is knowing what to throw away and knowing what to keep.” …

Feature

Battle for Alzheimer’s drugs finally over

October 8, 2010
Sales and Marketing Alzheimer's, Aricept, NICE

NICE is to allow wider access to Alzheimer’s disease treatments, ending an epic five year battle for access to the …

News
Jonathan_Claire

Trio of appointments at 4Sight

October 7, 2010
Sales and Marketing 4Sight, appointment, sales and marketing

Bracknell, UK-based Commercial services company 4Sight has made three high-level appointments. Jonathan Hartless (pictured) joins as operations director from an …

Appointment
GSK's Dr Pim Kon

Avandia should still be on the market, says GSK

October 7, 2010
Sales and Marketing Avandia, GlaxoSmithKline

GlaxoSmithKline believes European regulators were wrong to withdraw its diabetes drug Avandia from the market, but will not challenge their …

News

NICE announces change of heart on Alzheimer’s

October 7, 2010
Sales and Marketing Alzheimer's, Aricept, Ebixa, Exelon, NICE, Reminyl

NICE is set to update its guidance on treatments for Alzheimer´s disease, widening access to four drugs. The draft guidance …

News

GlaxoSmithKline review leads to 121 layoffs in Cork

October 7, 2010
Manufacturing and Production GlaxoSmithKline, Ireland, job cuts

GlaxoSmithKline has completed its review of a manufacturing facility in Ireland and concluded that it will have to shed 121 …

News

Pfizer ponders sale of Capsugel

October 7, 2010
Sales and Marketing Capsugel, Pfizer

Pfizer is reviewing options for its drug delivery systems business Capsugel, including a possible sale of the unit. Pfizer has …

News

New research on rules of engagement with doctors

October 7, 2010
Medical Communications Doctors.net.uk, digital, doctors.net

For doctors, the next 12 months will not only bring financial pressure and a raft of new health policies, it …

Feature
Appointments and Promotions

Pan Announces New Appointments and Promotions

October 6, 2010

PAN is pleased to announce two new appointments and three promotions. Andisheh Thomson joins as Account Manager and Natalie Enniks …

News
Press release

Merck to develop new class of antibacterials

October 6, 2010
Research and Development BioRelix, Merck & Co, anti-infectives

Merck & Co has signed a drug development agreement with anti-infective pharma firm BioRelix to development a new class of …

News

Intercell Biomedical appoints site director

October 6, 2010
Manufacturing and Production, Research and Development Intercell, appointment, research and development

Austrian biotech Intercell Biomedical has appointed Eric Frings as site director of its Livingston, Scotland operations.He joins the firm from …

Appointment

Novartis drops two drug candidates, takes $600 million hit

October 6, 2010
Research and Development Human Genome Sciences, Novartis, candidiasis, hepatitis

Novartis will incur a charge of nearly $600 million after it halted development of investigational drugs for hepatitis C and …

News

Talking R&D: eCTD challenges

October 6, 2010
Manufacturing and Production, Research and Development Talking R&D, eCTD, eCTD submissions

The eCTD was of course developed by the ICH (International Conference on Harmonisation) Expert Working Group to make it easier, …

Feature
GSK’s Seretide/Advair

New COPD and asthma treatments jostle for market space

October 6, 2010
Research and Development, Sales and Marketing COPD, Daxas, Onbrez Breezhaler, Revolair, asthma

Competition in the field of COPD and asthma is hotting up, with new data for several key treatments recently unveiled. …

Feature

Uncertainty over new cancer fund

October 6, 2010
Sales and Marketing Cancer, NHS, government

The UK government has launched its £50 million interim fund to give greater access to new cancer medicines. The new …

News

Janssen leads the pack at PM Society Digital Awards

October 6, 2010
Medical Communications Janssen, PM Society Digital Awards, disease awareness campaigns, pm society

Janssen was confirmed as one of the UK pharma industry’s most innovative pharma companies in the field of digital communications …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026